Optimizing prediction of new-baseline glomerular filtration rate after radical nephrectomy: are algorithms really necessary?


Journal

International urology and nephrology
ISSN: 1573-2584
Titre abrégé: Int Urol Nephrol
Pays: Netherlands
ID NLM: 0262521

Informations de publication

Date de publication:
Oct 2022
Historique:
received: 08 05 2022
accepted: 04 07 2022
pubmed: 18 7 2022
medline: 14 9 2022
entrez: 17 7 2022
Statut: ppublish

Résumé

Radical nephrectomy (RN) is an important consideration for the management of localized renal-cell-carcinoma (RCC) whenever the tumor appears aggressive, although reduced renal function is a concern. Split-renal-function (SRF) in the contralateral kidney and postoperative renal functional compensation (RFC) are fundamentally important for the accurate prediction of new baseline GFR (NBGFR) post-RN. SRF can be estimated either from nuclear renal scans (NRS) or from preoperative imaging using parenchymal-volume-analysis (PVA). We compare two SRF-based models for predicting NBGFR after RN with a subjective prediction of NBGFR by an experienced urologic-oncologist. 187 RCC patients managed with RN (2006-16) were included based on the availability of preoperative CT/MRI and NRS, and preoperative/postoperative eGFR. NBGFR was defined as the final GFR 3-12 months post-RN. For the SRF-based approaches, SRF was derived from either NRS or PVA, and RFC was estimated at 25% based on previous independent analyses. Thus, the formula (Global GFR The r values for subjective-assessment, NRS/SRF-based, and PVA/SRF-based approaches were 0.72/0.72/0.85, respectively (p < 0.05). The PVA/SRF-based model also demonstrated significant improvement across other performance parameters. The PVA/SRF-based model more accurately predicts NBGFR post-RN than NRS/SRF-based and Subjective Estimation. PVA software (Fujifilm-medical-systems) is readily available and affordable and provides accurate SRF estimations from routine preoperative imaging. This novel approach may inform clinical management regarding RN/PN for complex RCC cases.

Identifiants

pubmed: 35842890
doi: 10.1007/s11255-022-03298-y
pii: 10.1007/s11255-022-03298-y
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

2537-2545

Informations de copyright

© 2022. The Author(s), under exclusive licence to Springer Nature B.V.

Références

Campbell SC, Clark PE, Chang SS, Karam JA, Souter L, Uzzo RG (2021) Renal mass and localized renal cancer: evaluation, management, and follow-up: AUA guideline: Part I. J Urol 206(2):199–208. https://doi.org/10.1097/JU.0000000000001911
doi: 10.1097/JU.0000000000001911 pubmed: 34115547
Demirjian S, Lane BR, Derweesh IH, Takagi T, Fergany A, Campbell SC (2014) Chronic kidney disease due to surgical removal of nephrons: relative rates of progression and survival. J Urol 192(4):1057–1062. https://doi.org/10.1016/j.juro.2014.04.016
doi: 10.1016/j.juro.2014.04.016 pubmed: 24747655
Lane BR, Demirjian S, Derweesh IH et al (2015) Survival and functional stability in chronic kidney disease due to surgical removal of nephrons: importance of the new baseline glomerular filtration rate. Eur Urol 68(6):996–1003. https://doi.org/10.1016/j.eururo.2015.04.043
doi: 10.1016/j.eururo.2015.04.043 pubmed: 26012710
Wu J, Suk-Ouichai C, Dong W et al (2018) Analysis of survival for patients with chronic kidney disease primarily related to renal cancer surgery. BJU Int 121(1):93–100. https://doi.org/10.1111/bju.13994
doi: 10.1111/bju.13994 pubmed: 28834125
Sorbellini M, Kattan MW, Snyder ME, Hakimi AA, Sarasohn DM, Russo P (2006) Prognostic nomogram for renal insufficiency after radical or partial nephrectomy. J Urol 176(2):472–476. https://doi.org/10.1016/j.juro.2006.03.090
doi: 10.1016/j.juro.2006.03.090 pubmed: 16813869
Kim HL, Shah SK, Tan W et al (2009) Estimation and prediction of renal function in patients with renal tumor. J Urol 181(6):2451–2461. https://doi.org/10.1016/j.juro.2009.01.112
doi: 10.1016/j.juro.2009.01.112 pubmed: 19371883
Yokoyama M, Fujii Y, Takeshita H et al (2014) Renal function after radical nephrectomy: development and validation of predictive models in Japanese patients. Int J Urol 21(3):238–242. https://doi.org/10.1111/iju.12277
doi: 10.1111/iju.12277 pubmed: 24118492
Liss MA, DeConde R, Caovan D et al (2016) Parenchymal volumetric assessment as a predictive tool to determine renal function benefit of nephron-sparing surgery compared with radical nephrectomy. J Endourol 30(1):114–121. https://doi.org/10.1089/end.2015.0411
doi: 10.1089/end.2015.0411 pubmed: 26192380 pmcid: 4841003
Bhindi B, Lohse CM, Schulte PJ et al (2019) Predicting renal function outcomes after partial and radical nephrectomy. Eur Urol 75(5):766–772. https://doi.org/10.1016/j.eururo.2018.11.021
doi: 10.1016/j.eururo.2018.11.021 pubmed: 30477983
McIntosh AG, Parker DC, Egleston BL et al (2019) Prediction of significant estimated glomerular filtration rate decline after renal unit removal to aid in the clinical choice between radical and partial nephrectomy in patients with a renal mass and normal renal function. BJU Int 124(6):999–1005. https://doi.org/10.1111/bju.14839
doi: 10.1111/bju.14839 pubmed: 31145523 pmcid: 7654970
Aguilar Palacios D, Caraballo ER, Tanaka H et al (2020) Compensatory changes in parenchymal mass and function after radical nephrectomy. J Urol 204(1):42–49. https://doi.org/10.1097/JU.0000000000000797
doi: 10.1097/JU.0000000000000797 pubmed: 32073996
Aguilar Palacios D, Wilson B, Ascha M et al (2021) New baseline renal function after radical or partial nephrectomy: a simple and accurate predictive model. J Urol 205(5):1310–1320. https://doi.org/10.1097/JU.0000000000001549
doi: 10.1097/JU.0000000000001549 pubmed: 33356481
Tuttle KR, Alicic RZ, Duru OK et al (2019) Clinical characteristics of and risk factors for chronic kidney disease among adults and children: an analysis of the CURE-CKD registry. JAMA Netw Open 2(12):e1918169. https://doi.org/10.1001/jamanetworkopen.2019.18169
doi: 10.1001/jamanetworkopen.2019.18169 pubmed: 31860111 pmcid: 6991307
Tonelli M, Wiebe N, Guthrie B et al (2015) Comorbidity as a driver of adverse outcomes in people with chronic kidney disease. Kidney Int 88(4):859–866. https://doi.org/10.1038/ki.2015.228
doi: 10.1038/ki.2015.228 pubmed: 26221754
Rathi N, Palacios DA, Abramczyk E et al (2022) Predicting GFR after radical nephrectomy: the importance of split renal function. World J Urol 40(4):1011–1018. https://doi.org/10.1007/s00345-021-03918-9
doi: 10.1007/s00345-021-03918-9 pubmed: 35022828
Rathi N, Yasuda Y, Palacios DA et al (2022) Split renal function is fundamentally important for predicting functional recovery after radical nephrectomy. Eur Urol Open Sci 40:112–116. https://doi.org/10.1016/j.euros.2022.04.008
doi: 10.1016/j.euros.2022.04.008 pubmed: 35572817 pmcid: 9093013
Takagi T, Mir MC, Sharma N et al (2014) Compensatory hypertrophy after partial and radical nephrectomy in adults. J Urol 192(6):1612–1618. https://doi.org/10.1016/j.juro.2014.06.018
doi: 10.1016/j.juro.2014.06.018 pubmed: 24931802
Zabor EC, Furberg H, Lee B et al (2018) Long-term renal function recovery following radical nephrectomy for kidney cancer: results from a multicenter confirmatory study. J Urol 199(4):921–926. https://doi.org/10.1016/j.juro.2017.10.027
doi: 10.1016/j.juro.2017.10.027 pubmed: 29066363
Ye Y, Tanaka H, Wang Y et al (2020) Split renal function in patients with renal masses: utility of parenchymal volume analysis vs nuclear renal scans. BJU Int 125(5):686–694. https://doi.org/10.1111/bju.14997
doi: 10.1111/bju.14997 pubmed: 31971315
Komai Y, Sakai Y, Gotohda N, Kobayashi T, Kawakami S, Saito N (2014) A novel 3-dimensional image analysis system for case-specific kidney anatomy and surgical simulation to facilitate clampless partial nephrectomy. Urology 83(2):500–506. https://doi.org/10.1016/j.urology.2013.09.053
doi: 10.1016/j.urology.2013.09.053 pubmed: 24468517
Levey AS, Stevens LA, Schmid CH et al (2009) A new equation to estimate glomerular filtration rate. Ann Intern Med 150(9):604–612. https://doi.org/10.7326/0003-4819-150-9-200905050-00006
doi: 10.7326/0003-4819-150-9-200905050-00006 pubmed: 19414839 pmcid: 2763564
da Silva SL, Rech DL, de Souza V, Iwaz J, Lemoine S, Dubourg L (2019) diagnostic performance of creatinine-based equations for estimating glomerular filtration rate in adults 65 years and older. JAMA Intern Med 179(6):796–804. https://doi.org/10.1001/jamainternmed.2019.0223
doi: 10.1001/jamainternmed.2019.0223
Chang AR, Zafar W, Grams ME (2018) Kidney function in obesity-challenges in indexing and estimation. Adv Chronic Kidney Dis 25(1):31–40. https://doi.org/10.1053/j.ackd.2017.10.007
doi: 10.1053/j.ackd.2017.10.007 pubmed: 29499884 pmcid: 5836495
Mir MC, Campbell RA, Sharma N et al (2013) Parenchymal volume preservation and ischemia during partial nephrectomy: functional and volumetric analysis. Urology 82(2):263–268. https://doi.org/10.1016/j.urology.2013.03.068
doi: 10.1016/j.urology.2013.03.068 pubmed: 23791213
Shen D, Wu G, Suk HI (2017) Deep learning in medical image analysis. Annu Rev Biomed Eng 19:221–248. https://doi.org/10.1146/annurev-bioeng-071516-044442
doi: 10.1146/annurev-bioeng-071516-044442 pubmed: 28301734 pmcid: 5479722
Liu X, Faes L, Kale AU et al (2019) A comparison of deep learning performance against health-care professionals in detecting diseases from medical imaging: a systematic review and meta-analysis. Lancet Digit Health 1(6):e271–e297. https://doi.org/10.1016/S2589-7500(19)30123-2
doi: 10.1016/S2589-7500(19)30123-2 pubmed: 33323251
Heller N, Isensee F, Maier-Hein KH et al (2021) The state of the art in kidney and kidney tumor segmentation in contrast-enhanced CT imaging: Results of the KiTS19 challenge. Med Image Anal 67:101821. https://doi.org/10.1016/j.media.2020.101821
doi: 10.1016/j.media.2020.101821 pubmed: 33049579
Heller N, Tejpaul R, Isensee F et al (2022) Computer-generated R.E.N.A.L. nephrometry scores yield comparable predictive results to those of human-expert scores in predicting oncologic and perioperative outcomes. J Urol 207(5):1105–1115. https://doi.org/10.1097/JU.0000000000002390
doi: 10.1097/JU.0000000000002390 pubmed: 34968146
Spaliviero M, Poon BY, Aras O et al (2015) Interobserver variability of R.E.N.A.L., PADUA, and centrality index nephrometry score systems. World J Urol 33(6):853–858. https://doi.org/10.1007/s00345-014-1376-4
doi: 10.1007/s00345-014-1376-4 pubmed: 25149471
Simmons MN, Hillyer SP, Lee BH, Fergany AF, Kaouk J, Campbell SC (2012) Diameter-axial-polar nephrometry: integration and optimization of R.E.N.A.L. and centrality index scoring systems. J Urol 188(2):384–390. https://doi.org/10.1016/j.juro.2012.03.123
doi: 10.1016/j.juro.2012.03.123 pubmed: 22698624

Auteurs

Nityam Rathi (N)

Center for Urologic Oncology, Glickman Urological and Kidney Institute, Room Q10-120, 9500 Euclid Avenue, Cleveland Clinic, Cleveland, OH, USA.

Yosuke Yasuda (Y)

Center for Urologic Oncology, Glickman Urological and Kidney Institute, Room Q10-120, 9500 Euclid Avenue, Cleveland Clinic, Cleveland, OH, USA.
Department of Urology, Tokyo Medical and Dental University, Tokyo, Japan.

Worapat Attawettayanon (W)

Center for Urologic Oncology, Glickman Urological and Kidney Institute, Room Q10-120, 9500 Euclid Avenue, Cleveland Clinic, Cleveland, OH, USA.
Division of Urology, Department of Surgery, Faculty of Medicine, Songklanagarind Hospital, Prince of Songkla University, Songkhla, Thailand.

Diego A Palacios (DA)

Center for Urologic Oncology, Glickman Urological and Kidney Institute, Room Q10-120, 9500 Euclid Avenue, Cleveland Clinic, Cleveland, OH, USA.

Yunlin Ye (Y)

Center for Urologic Oncology, Glickman Urological and Kidney Institute, Room Q10-120, 9500 Euclid Avenue, Cleveland Clinic, Cleveland, OH, USA.
Department of Urology, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Sun Yat-Sen University Cancer Center, Guangzhou, China.

Jianbo Li (J)

Department of Quantitative Health Sciences, Cleveland Clinic, Cleveland, OH, USA.

Christopher Weight (C)

Center for Urologic Oncology, Glickman Urological and Kidney Institute, Room Q10-120, 9500 Euclid Avenue, Cleveland Clinic, Cleveland, OH, USA.

Mohammed Eltemamy (M)

Center for Urologic Oncology, Glickman Urological and Kidney Institute, Room Q10-120, 9500 Euclid Avenue, Cleveland Clinic, Cleveland, OH, USA.

Tarik Benidir (T)

Center for Urologic Oncology, Glickman Urological and Kidney Institute, Room Q10-120, 9500 Euclid Avenue, Cleveland Clinic, Cleveland, OH, USA.

Robert Abouassaly (R)

Center for Urologic Oncology, Glickman Urological and Kidney Institute, Room Q10-120, 9500 Euclid Avenue, Cleveland Clinic, Cleveland, OH, USA.

Steven C Campbell (SC)

Center for Urologic Oncology, Glickman Urological and Kidney Institute, Room Q10-120, 9500 Euclid Avenue, Cleveland Clinic, Cleveland, OH, USA. campbes3@ccf.org.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH